Biologics

Orthopedic surgeon Sunny Patel, MD, performed a new knee cartilage replacement procedure at Burlington, N.C.-based Alamance Regional Medical Center, the Times-News reports.

Biological Industries USA and StemExpress partnered to distribute StemExpress' human bone marrow-derived mesenchymal stem cells.

Cytokines present in umbilical cord blood-derived products can stimulate cellular processes necessary for bone regeneration, according to a study in Regenerative Medicine.

The global orthobiologics market is projected to reach $10.1 billion by 2025, according to Market Insights Reports.

Anika Therapeutics appointed Susan Vogt to its board of directors.

Degenerative disc disease patients who received intradiscal injections of SpinalCyte's CybroCell showed sustained pain relief improvement and greater back mobility after 12 months, according to the results of a phase 1/2 clinical trial.

Regentis Biomaterials expanded its clinical trial of GelrinC for the treatment of articular knee cartilage damage to 11 U.S. sites.

BoneSupport launched its own U.S. distributor network.

Three Los Angeles-based Cedars-Sinai investigators developed a method to harness stem cells to regrow tissue damaged by major trauma. The Department of Defense and National Institutes of Health awarded the researchers $8 million in grants.

Kuros Biosciences' Dutch subsidiary Kuros Biosciences BV received a U.S. patent.